Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease

British Journal of Ophthalmology

Volumn 84, Issue 2, 2000, Pages 154-157

  Cahill, Mark ^a,e   Karabatzaki, Maria ^a   Meleady, Ray ^b   Refsum, Helga ^c   Ueland, Per ^c   Shields, Denis ^d   Mooney, David ^a   Graham, Ian ^b  

^a ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

^c UNIVERSITY OF BERGEN   (Norway)

^d ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^e MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PLASMA; PRIORITY JOURNAL; RETINA ARTERY OCCLUSION; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; CASE-CONTROL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; MALE; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0034100878     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.2.154     Document Type: Article

References (29)

1. Carson NA, Neill DW. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child 1962;37:505-13.
2. Mudd SH, Levy HL, Skovby F. Disorders of transsulphuration. In: Schriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. 6th ed. New York: McGraw Hill, 1989;1:693-734.
3. McCully KS. Homocysteine theory of arteriosclerosis: development and current status. Atheroscler Rev 1983;11: 157-246.
4. Den Heijer M, Rosendaal FR, Blom HJ, et al. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 1998;80:874-7.
5. Den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759-62.
6. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-50.
7. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277: 1775-81.
8. Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
9. Selhub J, Jacques PF, Wilson PWF, et al. Vitamin status and intake as primary determinants of homocysteinaemia in an elderly population. JAMA 1993;270:2693-8.
10. Clarke R, Collins R. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease. J Cardiovasc Risk 1998;5:249-55.
11. Williamson TH. Central retinal vein occlusion: what's the story? Br J Ophthalmol 1997;81:698-704.
12. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains eye study. Arch Ophthalmol 1996;114:1243-7.
13. The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996; 114:545-54.
14. Mangat HS. Retinal artery occlusion. Surv Ophthalmol 1995;40:145-56.
15. Greven CM, Slusher MM, Weaver RG. Retinal arterial occlusions in young adults. Am J Ophthalmol 1995;120: 776-83.
16. Destro M, Gragoudas ES. Arterial occlusion. In: Albert DM, Jakobiec FA, eds. Principles and practice of ophthalmology: clinical practice. Vol 3. Philidelphia: WB Saunders, 1994:727-35.
17. Biousse V, Newman NJ, Sternberg P Jr. Retinal vein occlusion and transient monocular visual loss associated with hyperhomocysteinemia. Am J Ophthalmol 1997;124:257-60.
18. Berg W van der, Verbraak FD, Bos PJ. Homocystinuria presenting as central retinal artery occlusion and longstanding thromboembolic disease. Br J Ophthalmol 1990;74:696-7.
19. Wenzler EM, Rademakers AJ, Boers GH, et al. Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol 1993;115:162-7.
20. Fiskerstrand T, Refsum H, Kvalheim G, et al. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993;39:263-71.
21. Mandel H, Brenner B, Berant M, et al. Coexistence of hereditary homocystinuria and factor V Leiden - effect on thrombosis. N Engl J Med 1996;334:763-8
22. Williamson TH, Rumley A, Lowe GD. Blood viscosity, coagulation and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 1996;80:203-8
23. Larsson J, Olafsdottir F, Bauer D. Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 1996;80:200-2.
24. Dhote R, Bachmeyer C, Horrellou MH, et al. Central retinal vein thrombosis associated with resistance to activated protein C. Am J Ophthalmol 1995;120:388-9.
25. Williamson TH, Baxter GM, Lowe GD. Influence of age, systemic blood pressure, smoking and blood viscosity on orbital blood velocities. Br J Ophthalmol 1995;79:17-22.
26. Peduzzi M, Debbia A, Guerrieri F, et al. Abnormal blood rheology in retinal vein occlusion. A preliminary report. Graefes Arch Clin Exp Ophthalmol 1986;224:83-5.
27. Trope GE, Lowe GD, McArdle BM, et al. Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion. Br J Ophthalmol 1983;67:137-42.
28. Russel RW. The source of retinal emboli. Lancet 1968;2: 789-92.
29. Hollenhurst RW. Vascular status of patients who have cholesterol emboli in the retina. Am J Ophthalmol 1966;61: 1159-65.